As for selenoproteins, the body of evidence suggests that the suppression of SELENOP may provide a valuable therapeutic approach to improving glucose metabolism and treating T2D and its vascular complications [175]. This evidence concerns the gene SELENOS and type 2 diabetes mellitus.